We are live on ! Find out more
QNTM

Quantum Biopharma Class B Subordinate Voting Shares

6 hedge funds and large institutions have $12K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
6
Holders Change
+6
Holders Change %
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

QNTM Hedge Fund Activity: Q1 2020 in Review

6 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q1 2020, worth a combined $12K.

Buyers outnumbered sellers: 6 funds opened new QNTM positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $8.28K.

  • 6 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $12K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q1 2020.
  • 6 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q1 2020 and 0 closed out, a net change of +6 holders.
  • The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q1 2020 was Bank of Montreal, an estimated $8.28K added.

Based on aggregated 13F filings for Q1 2020.